Concepedia
1
Publications
19
Citations
H-Index
2023
Active since
Affiliations
Novo Nordisk (Denmark)(Current)
Caroline Ø. Lindahl is an author at Novo Nordisk (Denmark).
Publications per year
2023–2023
Real‐world impact of once‐weekly subcutaneous semaglutide after 2 years of follow‐up: Results from a nationwide observational study in people with type 2 diabetes
Tina Vilsbøll, Caroline Ø. Lindahl, NICK F. NIELSEN et al. · Diabetes Obesity and Metabolism · 2023 · 19 citations · Full text
Rows per page
1–1 of 1